CO.ACTOR FOR PHARMA
People listen to people.
Your 20 Years of Pharma Expertise Are Invisible on LinkedIn. Let's Fix That.
Co.Actor learns your scientific voice in a 15-minute interview, then keeps you visible to every partner, investor, and KOL in your network — with FDA-safe guardrails built in.
Trusted by pharma executives who build scientific credibility and attract partners through LinkedIn
GSK's CEO grew 55% on LinkedIn last year. Your VP of BD has 3 posts from 2021.
Without LinkedIn presence
- Licensing partnersDon't know you exist
- InvestorsCan't find your perspective
- KOLs in your areaEngage with competitors
- Your scienceLocked in slide decks
With consistent posting
- Licensing partnersReach out to you first
- InvestorsAlready familiar with your thesis
- KOLs in your areaComment on your posts
- Your scienceSeen by thousands weekly
The pharma executives winning partnerships and investor attention are the ones who show up consistently on LinkedIn — sharing real scientific perspective, not press releases. Co.Actor makes that possible in 5 minutes a day, with FDA-safe guardrails built in.
From compliance fear to consistent presence — in 15 minutes per week
Tell us how you think
A 15-minute voice interview captures your scientific vocabulary, your perspective on the field, your analytical style. Co.Actor learns to write like you — not like a press release or a corporate blog.
Set your compliance guardrails
Load your company's approved messaging, prohibited topics, required disclaimers. FDA off-label rules, fair balance requirements — configured once, applied to every post automatically.
Review, edit, post
5 minutes of polishing. Co.Actor generates drafts in your scientific voice, within your guardrails. You review, adjust, approve. Done before your first meeting.
TRADITIONAL APPROACH
Research topic: 30 min Draft post: 45 min MLR/compliance check: 20 min Total: ~95 min/post
WITH CO.ACTOR
Review draft: 3 min Edit if needed: 2 min Approve & schedule: 1 min Total: ~6 min/post
Pharma leaders already winning on LinkedIn. See how they do it.
Executives at Novartis, Novo Nordisk, and leading biotechs build pipeline and attract partners through consistent thought leadership. These posts show what's possible.
AI that sounds like a scientist, not like a press release
Generic AI produces corporate language your audience scrolls past. Co.Actor captures how you actually think — your clinical analysis, competitive insights, development philosophy. The result: posts that sound like the executive who actually understands the science.
Generic AI output
“Excited to share that our company is making great progress in our oncology pipeline and we look forward to continued innovation.”
Co.Actor output
“The Phase 2 data on PI3K resistance mechanisms just changed how I think about second-line therapy selection in NSCLC. Here's why the field hasn't caught up yet.”
Content that builds scientific credibility — not just fills your feed
Co.Actor suggests topics tailored to your therapeutic area and expertise. Here's what your LinkedIn feed will look like:
Pipeline Commentary
"The Phase 3 readout on [mechanism] shifts the competitive landscape in NSCLC. Here's what I'm watching..."
Positions you as the scientific voice investors and partners want to follow
Disease Awareness
"We talk about rare disease diagnosis delays — but here's what the data actually shows about the patient journey..."
Builds thought leadership in your therapeutic area without promotional risk
Industry Trends
"AI in drug discovery sounds exciting. After 3 years of working with these platforms, here's what actually moves the needle..."
Shows you understand the landscape beyond your own company
Conference Takeaways
"3 abstracts from ASCO that nobody is talking about — and why they matter more than the headline data"
Demonstrates you're engaged with the scientific community
Partnership Signals
"What I look for in a licensing partner — and the 3 red flags that kill deals before they start"
Attracts the right BD conversations without pitching
Leadership Perspective
"What 15 years in biotech taught me about the difference between a promising molecule and a successful drug"
Creates emotional connection and positions you as a trusted voice
What 90 days of consistent posting does to your deal pipeline
LinkedIn rewards consistency over virality. Here's the typical trajectory for pharma executives who post 2-3x per week:
Foundation
- ✓Voice interview completed
- ✓Compliance guardrails configured
- ✓First 3 posts drafted and approved
Momentum
- ✓Posting 2-3x/week in your voice
- ✓KOLs and peers start engaging
- ✓Profile views increase 3-5x
Recognition
- ✓"I keep seeing your posts" at conferences
- ✓Connection requests from target partners
- ✓Journalists reach out for commentary
Results
- ✓Inbound BD inquiries from LinkedIn
- ✓Speaking and panel invitations
- ✓You're the executive people think of first
Built for every pharma executive who needs to be visible
Chief Business Officer
“Build partnership deal flow through consistent scientific presence”
Weekly posts on licensing trends, deal structures, and therapeutic area perspectives. Partners see consistent expertise before the first meeting. Compliance guardrails catch anything approaching off-label territory.
Biotech Founder / CEO
“Build investor familiarity before the Series B roadshow”
Weekly content about unmet need, clinical rationale, and industry commentary — within FDA safe harbor. By roadshow: warm contacts at target VCs who already follow your thinking.
Solo Consultant
“Attract pharma clients through visible expertise — without a sales team”
You don't need a BD team. You need a consistent voice. 2-3 posts a week sharing your regulatory, clinical, or commercial perspective. Co.Actor handles the writing so you can focus on client work.
Frequently Asked Questions
The expertise that closes deals shouldn't be invisible
Join pharma and biotech executives who post consistently and attract partners through LinkedIn presence.
No credit card required · FDA-safe guardrails built in · 15-minute voice interview to get started